1. CBER/FDA Memorandum. Summary of CBER considerations on selected aspects of active controlled trial design and analysis for the evaluation of thrombolytics in acute MI, June 1999.
2. International Conference on Harmonisation. Guidance on choice of control group and related design and conduct issues in clinical trials (ICH E-10). International Conference on Harmonization, July 2000.
3. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics